Tag Archive | "Boehringer Ingelheim"

Partnering with Boehringer Ingelheim: Looking for new opportunities

Tags: , , ,


Boehringer Ingelheim is a top pharma company active in partnering, licensing and M&A in pharmaceuticals Read the full story

Boehringer Ingelheim: Partnering activity 2005-2013

Tags: , ,


Boehringer Ingelheim announced over 120 partnering / licensing deals since 2005, with 18 deals in 2012 alone Read the full story

Boehringer Ingelheim: M&A activity 2005-2013

Tags: , ,


Boehringer Ingelheim has announced only 2 M&A deals since 2005, with the acquisition of SSP and Actimis Pharmaceuticals Read the full story

Boehringer Ingelheim pharma deals for $3.27 million of diabetes research grants

Tags: , , ,


The Boehringer Ingelheim and European Foundation for the Study of Diabetes entered pharma deals to fund European-wide diabetes research. Read the full story

Boehringer Ingelheim pharma partners Healthrageous and United BioSource for type 2 diabetes research collaboration

Tags: , , ,


Boehringer Ingelheim, a big pharma company, have entered deals with pharma partners United BioSource for type 2 diabetes research. Read the full story

Boehringer Ingelheim in biotech deals with Valneva for EB66 licensing

Tags: , , ,


Valneva has entered biotech deals with Boehringer Ingelheim for the licensing of EB66 cell line for the development of animal health vaccines. Read the full story

Boehringer Ingelheim

Tags: , ,


Boehringer Ingelheim is a top pharmaceutical company based in Ingelheim, Germany Read the full story

Boehringer Ingelheim big pharma deals Athera Biotech for novel cardiovascular antibody option agreement

Tags: , , ,


Athera Biotechnologies has entered into pharma deals involving an option agreement with Boehringer Ingelheim on a novel preclinical antibody program. Read the full story

Boehringer Ingelheim: Company Profile

Tags: ,


Boehringer Ingelheim, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Humana and Boehringer Ingelheim announce pharma partnering deal

Tags: , , ,


Humana and Boehringer Ingelheim, a big pharma company, announced a multi-year pharma partnering collaboration dedicated to improving health care and reducing costs for people affected by chronic obstructive pulmonary disease, cardiovascular disease, and other chronic disease states. Read the full story

cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cabannerad300x150new4gif
e80banner300x150animgif
a1banner300x150animgif